链接：https://www.antibodysystem.com/product/21631.html
名称：InVivoMAb Anti-Mouse CD198/CCR8 Antibody (Iv0255)体内中和抗体，活性抗体
别名：C-C chemokine receptor type 8, C-C CKR-8, CC-CKR-8, CCR-8, CDw198, Ccr8, Cmkbr8, Ter1，CD198/CCR8抗体
货号：VME85601
宿主：Mouse
适用物种：Mouse
存储缓冲区：0.01M PBS, pH 7.4.
形式：Liquid
纯度：>95%
克隆：Monoclonal
同型：IgG2a, kappa
应用：ELISA, Neutralization
内毒素水平：Please contact with the lab for this information.
UniProt：P56484
用途范围：仅用于科研
储存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
如果您对CD198/CCR8感兴趣可以咨询我们相关产品：
Research Grade Anti-Human CD198/CCR8 (CM369) (DHE85607)
Research Grade Anti-Human CD198/CCR8 (HFB101110) (DHE85604)
Research Grade Anti-Human CD198/CCR8 (SRF114) (DHE85603)
Research Grade Anti-Human CD198/CCR8 (FPA157) (DHE85602)
Research Grade Anti-Human CD198/CCR8 (BMS-986340) (DHE85605)
InVivoMAb Anti-Rat CD198/CCR8 Antibody (Iv0256) (VRE85601)
InVivoMAb Anti-Mouse CD198/CCR8 Antibody (Iv0255) (VME85601)
Research Grade Anti-Human CD198/CCR8 (GS-1811/JTX-1811) (DHE85601)
Anti-Human CD198/CCR8 Antibody (SAA1405) (FHE85620)
Anti-Human CD198/CCR8 Antibody (21360) (FHE85610)
Recombinant Human CD198/CCR8, N-His (YHE85601)
免费热线：027-65279366 /18108604356
QQ：2663991332
咨询邮箱：products@biolabreagent.com
选购商城：https://www.antibodysystem.com
微信公众平台：佰乐博生物Biolab Reagents
参考文献：
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory. PMID: 35140181
Chemokine Receptor-Targeted Therapies: Special Case for CCR8. PMID: 35158783
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. PMID: 36352891
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells. PMID: 37420296
Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. PMID: 35973731
CD4(+)CCR8(+) Tregs in ovarian cancer: a potential effector Tregs for immune regulation. PMID: 37950246
Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. PMID: 37770937
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer. PMID: 35354899
TGF-beta-induced CCR8 promoted macrophage transdifferentiation into myofibroblast-like cells. PMID: 35377281
CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications. PMID: 38001911
CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-gamma Producing Innate Lymphoid CelIs and Protects From Experimental Colitis. PMID: 33613532
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer. PMID: 32367308
Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. PMID: 36173487
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies. PMID: 35693763
